Valsartan Sacubitril Sodium Hemipentahydrate Salt – CAS 936623-90-4

Pharmaffiliates offers Valsartan Sacubitril Sodium Hemipentahydrate Salt (CAS 936623-90-4), a high-purity pharmaceutical intermediate widely used in the synthesis of Entresto®, a combination therapy for heart failure and hypertension management.

This compound plays a pivotal role in the development of cardiovascular therapies. Its primary applications include:

• Heart Failure Treatment: A crucial ingredient in Entresto® to reduce cardiovascular death and hospitalization in heart failure patients.

• Hypertension Management: Effective in lowering blood pressure for hypertensive patients.

• Cardiovascular Drug Research: Used in pharmaceutical R&D as a reference standard for formulation development and impurity profiling

Pharmaffiliates maintains the highest quality standards to ensure product integrity. Each batch is supplied with:

• Certificate of Analysis (COA)

• Material Safety Data Sheet (MSDS)

• Spectral Data – NMR, HPLC, LC-MS (available on request)

Disclaimer

The PASL product information for any accuracy or completeness is as per the existing knowledge furnished during the creation of the webpage.

The purchaser, user or importer of record is responsible for determining the accuracy of items at the time of ordering, as it may change without notice as per current PASL product specification.